Rxwire
In the news · 48h FDA 40 Eli Lilly 23 Roche 11 Merck & Co. (MSD) 9 Johnson & Johnson 8 AstraZeneca 3 Daiichi Sankyo 3 Bayer 2
Trials & R&D · first seen 2h ago, updated 2h ago

EU clears first drug therapy for rare disease cALD

1 outlet

EU clears first drug therapy for rare disease cALD Phil.Taylor Fri, 25/09/2026 - 12:25

Summary from pharmaphorum.

Coverage 1 article · 1 outlet

  1. pharmaphorum
    EU clears first drug therapy for rare disease cALD